Minor groove binder antibody conjugates employing a water soluble β-glucuronide linker

The minor groove binder β-glucuronide drug-linker 3 was constructed from amino CBI 1 and determined to be a substrate for Escherichia coli β-glucuronidase (EC 3.2.1.31), resulting in facile drug release. Compound 3 was conjugated to mAbs cAC10 (anti-CD30) and h1F6 (anti-CD70) to give antibody-drug c...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters Vol. 17; no. 8; pp. 2278 - 2280
Main Authors: Jeffrey, Scott C., Nguyen, Minh T., Moser, Ruth F., Meyer, Damon L., Miyamoto, Jamie B., Senter, Peter D.
Format: Journal Article
Language:English
Published: Oxford Elsevier Ltd 15-04-2007
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The minor groove binder β-glucuronide drug-linker 3 was constructed from amino CBI 1 and determined to be a substrate for Escherichia coli β-glucuronidase (EC 3.2.1.31), resulting in facile drug release. Compound 3 was conjugated to mAbs cAC10 (anti-CD30) and h1F6 (anti-CD70) to give antibody-drug conjugates (ADCs) with potencies comparable to that of free drug 1. The ADCs were largely monomeric at intermediate loading levels (4–5 drug/mAb), in contrast to highly aggregated p-aminobenzylcarbamate dipeptide-based ADCs of 1 previously reported. Significant levels of immunologic specificity were observed with cAC10- 3 by comparing antigen positive versus negative cell lines and binding versus non-binding control ADCs. The water soluble β-glucuronide linker is stable in plasma and effectively delivers drugs to target cells leading to potent cytotoxic activities.
AbstractList The minor groove binder β-glucuronide drug-linker 3 was constructed from amino CBI 1 and determined to be a substrate for Escherichia coli β-glucuronidase (EC 3.2.1.31), resulting in facile drug release. Compound 3 was conjugated to mAbs cAC10 (anti-CD30) and h1F6 (anti-CD70) to give antibody-drug conjugates (ADCs) with potencies comparable to that of free drug 1. The ADCs were largely monomeric at intermediate loading levels (4–5 drug/mAb), in contrast to highly aggregated p-aminobenzylcarbamate dipeptide-based ADCs of 1 previously reported. Significant levels of immunologic specificity were observed with cAC10- 3 by comparing antigen positive versus negative cell lines and binding versus non-binding control ADCs. The water soluble β-glucuronide linker is stable in plasma and effectively delivers drugs to target cells leading to potent cytotoxic activities.
The minor groove binder beta -glucuronide drug-linker 3 was constructed from amino CBI 1 and determined to be a substrate for Escherichia coli beta -glucuronidase (EC 3.2.1.31), resulting in facile drug release. Compound 3 was conjugated to mAbs cAC10 (anti-CD30) and h1F6 (anti-CD70) to give antibody-drug conjugates (ADCs) with potencies comparable to that of free drug 1. The ADCs were largely monomeric at intermediate loading levels (4-5 drug/mAb), in contrast to highly aggregated p-aminobenzylcarbamate dipeptide-based ADCs of 1 previously reported. Significant levels of immunologic specificity were observed with cAC10- 3 by comparing antigen positive versus negative cell lines and binding versus non-binding control ADCs. The water soluble beta -glucuronide linker is stable in plasma and effectively delivers drugs to target cells leading to potent cytotoxic activities.
The minor groove binder beta-glucuronide drug-linker 3 was constructed from amino CBI 1 and determined to be a substrate for Escherichia coli beta-glucuronidase (EC 3.2.1.31), resulting in facile drug release. Compound 3 was conjugated to mAbs cAC10 (anti-CD30) and h1F6 (anti-CD70) to give antibody-drug conjugates (ADCs) with potencies comparable to that of free drug 1. The ADCs were largely monomeric at intermediate loading levels (4-5drug/mAb), in contrast to highly aggregated p-aminobenzylcarbamate dipeptide-based ADCs of 1 previously reported. Significant levels of immunologic specificity were observed with cAC10-3 by comparing antigen positive versus negative cell lines and binding versus non-binding control ADCs. The water soluble beta-glucuronide linker is stable in plasma and effectively delivers drugs to target cells leading to potent cytotoxic activities.
Author Meyer, Damon L.
Jeffrey, Scott C.
Senter, Peter D.
Moser, Ruth F.
Nguyen, Minh T.
Miyamoto, Jamie B.
Author_xml – sequence: 1
  givenname: Scott C.
  surname: Jeffrey
  fullname: Jeffrey, Scott C.
  email: sjeffrey@seagen.com
– sequence: 2
  givenname: Minh T.
  surname: Nguyen
  fullname: Nguyen, Minh T.
– sequence: 3
  givenname: Ruth F.
  surname: Moser
  fullname: Moser, Ruth F.
– sequence: 4
  givenname: Damon L.
  surname: Meyer
  fullname: Meyer, Damon L.
– sequence: 5
  givenname: Jamie B.
  surname: Miyamoto
  fullname: Miyamoto, Jamie B.
– sequence: 6
  givenname: Peter D.
  surname: Senter
  fullname: Senter, Peter D.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18658327$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/17293111$$D View this record in MEDLINE/PubMed
BookMark eNp9kMFu1DAQhi1URLeFF-CAfIFbgidx7FjigiooSEVcQHCzHHuy8uLYi50U7WvxIDxTs9qVeuM00uj7f818V-QipoiEvARWAwPxdlcPkw11w5isGdRMwhOyAS541XLWXZANU4JVveI_L8lVKTvGgDPOn5FLkI1qAWBDfnzxMWW6zSndIx18dJipibMfkjtQm-Ju2ZoZC8VpH9LBxy019M-6ybSksAwB6b-_1TYsdskpeoc0-PgL83PydDSh4IvzvCbfP374dvOpuvt6-_nm_V1lOXRz1fai6zonQSqhlEQje8lbtJyjEdwNxlqUApwS0PRj0ze2VaPAQQ2mx1HJ9pq8OfXuc_q9YJn15IvFEEzEtBQNSiopFV_B5gTanErJOOp99pPJBw1MH3XqnT7q1EedmoFeda6hV-f2ZZjQPUbO_lbg9RkwxZowZhOtL4_c-l7fNscz3504XF3ce8y6WI_RovMZ7axd8v-74wFfj5bI
CitedBy_id crossref_primary_10_1111_cbdd_12085
crossref_primary_10_3390_toxins3070848
crossref_primary_10_1021_bc9001097
crossref_primary_10_1002_biot_201200250
crossref_primary_10_1002_cmdc_201100114
crossref_primary_10_1158_1535_7163_MCT_14_0212
crossref_primary_10_1038_s41392_022_00947_7
crossref_primary_10_3390_ijms17040561
crossref_primary_10_1097_PPO_0b013e318172d704
crossref_primary_10_1021_ml100039h
crossref_primary_10_1021_mp500781a
crossref_primary_10_4155_tde_14_63
crossref_primary_10_1021_acs_bioconjchem_3c00363
crossref_primary_10_3816_CLM_2009_n_024
crossref_primary_10_1158_1535_7163_MCT_16_0343
crossref_primary_10_1177_2472555220912955
crossref_primary_10_4062_biomolther_2015_116
crossref_primary_10_3390_biomedicines12030500
crossref_primary_10_3390_biomedicines9080872
crossref_primary_10_1021_acs_jmedchem_7b00563
crossref_primary_10_1158_1535_7163_MCT_14_0040_T
crossref_primary_10_3390_ijms161023784
crossref_primary_10_1016_j_ejmech_2017_08_008
crossref_primary_10_1158_1535_7163_MCT_16_0641
crossref_primary_10_1080_00914037_2015_1038818
crossref_primary_10_1002_jhet_591
crossref_primary_10_1016_j_bmc_2017_04_010
crossref_primary_10_1039_D1CC00957E
crossref_primary_10_1016_j_drup_2014_11_001
crossref_primary_10_1016_j_bmcl_2022_128953
crossref_primary_10_3390_ph14050442
crossref_primary_10_1186_s40164_024_00493_8
crossref_primary_10_1158_1535_7163_MCT_16_0038
crossref_primary_10_1007_s00280_012_1925_8
crossref_primary_10_1021_bc800289a
crossref_primary_10_1021_bc9002019
crossref_primary_10_3923_ijp_2017_785_807
Cites_doi 10.1002/ijc.10207
10.1021/jm990136b
10.1097/01.ju.0000158121.49085.ba
10.1038/nbt832
10.1016/S0968-0896(00)82007-6
10.1021/bc0600214
10.1016/S0960-894X(01)00707-7
10.1021/jo0263115
10.1016/S0968-0896(00)00157-7
10.1021/jm040137q
10.1200/JCO.2000.18.11.2282
10.1097/00000478-200005000-00014
10.1248/cpb.43.378
10.1021/bc025536j
10.1021/bc0502917
10.1038/nbt1141
10.4049/jimmunol.159.10.4959
10.1021/bc050201y
10.1124/jpet.103.060533
ContentType Journal Article
Copyright 2007 Elsevier Ltd
2007 INIST-CNRS
Copyright_xml – notice: 2007 Elsevier Ltd
– notice: 2007 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7QO
8FD
C1K
FR3
P64
DOI 10.1016/j.bmcl.2007.01.071
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList
Engineering Research Database
MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Chemistry
EISSN 1464-3405
EndPage 2280
ExternalDocumentID 10_1016_j_bmcl_2007_01_071
17293111
18658327
S0960894X07001217
Genre Journal Article
GroupedDBID ---
--K
--M
.HR
.~1
0R~
1B1
1RT
1~.
1~5
23N
4.4
457
4G.
53G
5GY
5VS
6TJ
7-5
71M
8P~
9JM
9JN
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARLI
AATCM
AAXUO
ABBQC
ABFNM
ABGSF
ABJNI
ABLVK
ABMAC
ABMZM
ABTAH
ABUDA
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFS
ACIUM
ACNNM
ACRLP
ADBBV
ADECG
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AENEX
AFFNX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJSZI
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
D0L
DOVZS
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FLBIZ
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEA
HMK
HMO
HMS
HMT
HVGLF
HZ~
IHE
J1W
KOM
LCYCR
LZ2
M29
M2Z
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCB
SCC
SDF
SDG
SDP
SES
SEW
SOC
SPC
SPCBC
SPT
SSH
SSK
SSP
SSU
SSZ
T5K
WUQ
XFK
XPP
Y6R
YK3
ZMT
ZY4
~02
~G-
ABPIF
ABPTK
IQODW
AAXKI
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
AFJKZ
CITATION
7QL
7QO
8FD
C1K
FR3
P64
ID FETCH-LOGICAL-c415t-386555d71796997ea78743ec44ea64dbacce761d96128f282c39f6eb9ba8ef973
ISSN 0960-894X
IngestDate Fri Oct 25 23:56:46 EDT 2024
Thu Sep 26 16:09:25 EDT 2024
Sat Sep 28 07:55:49 EDT 2024
Sun Oct 22 16:06:44 EDT 2023
Fri Feb 23 02:27:55 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Drug
β-Glucuronidase
Conjugate
Antibody
Drug-linker
h1F6
Linker
Aggregation
Minor groove binder
Targeted
Anti-CD30
cAC10
Delivery
Monoclonal
β-Glucuronide
Release
Anti-CD70
Cancer
Spacer arm
hlF6
Escherichia coli
Cytotoxicity
Monoclonal antibody
Organic carbamate
Glucuroconjugate
Lymphoproliferative syndrome
Bacteria
Chemical synthesis
Tumor cell
Enterobacteriaceae
Minor groove
Enzyme
Hodgkin disease
Malignant hemopathy
In vitro
Lymphoma
Biological activity
Substrate
Water soluble compound
Cell line
Glycosidases
Uronic acid
Hydrolases
Conjugated compound
O-Glycosidases
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c415t-386555d71796997ea78743ec44ea64dbacce761d96128f282c39f6eb9ba8ef973
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 17293111
PQID 19797794
PQPubID 23462
PageCount 3
ParticipantIDs proquest_miscellaneous_19797794
crossref_primary_10_1016_j_bmcl_2007_01_071
pubmed_primary_17293111
pascalfrancis_primary_18658327
elsevier_sciencedirect_doi_10_1016_j_bmcl_2007_01_071
PublicationCentury 2000
PublicationDate 2007-04-15
PublicationDateYYYYMMDD 2007-04-15
PublicationDate_xml – month: 04
  year: 2007
  text: 2007-04-15
  day: 15
PublicationDecade 2000
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: England
PublicationTitle Bioorganic & medicinal chemistry letters
PublicationTitleAlternate Bioorg Med Chem Lett
PublicationYear 2007
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Yasuzawa, Muroi, Ichimura, Takahashi, Ogawa, Takahashi, Sano, Saitoh (bib3) 1995; 43
Atwell, Milbank, Wilson, Hogg, Denny (bib6) 1999; 42
Boger, Johnson, Yun, Tarby (bib5) 1994; 2
Jeffrey, Torgov, Andreyka, Boddington, Cerveny, Denny, Gordon, Gustin, Haugen, Kline, Nguyen, Senter (bib7) 2005; 48
Wahl, Klussman, Thompson, Chen, Francisco, Risdon, Chace, Siegall, Francisco (bib11) 2002; 62
Dubowchik, Firestone, Padilla, Willner, Hofstead, Mosure, Knipe, Lasch, Trail (bib21) 2002; 13
Walker, Dubowchik, Hofstead, Trail, Firestone (bib22) 2002; 12
Wu, Senter (bib20) 2005; 23
Liang, B. S. C.; Sanjeev, G.; Vincent, G.; Killian, H.; Li, Z. -H.; Bidal, S. In
Yang, Denny (bib10) 2002; 67
Tesselaar, Gravestein, van Schijndel, Borst, van Lier (bib16) 1997; 159
Junker, Hindermann, von Eggeling, Diegmann, Haessler, Schubert (bib12) 2005; 173
Suzawa, Nagamura, Saito, Ohta, Hanai, Yamasaki (bib9) 2000; 8
Sun, Beam, Cerveny, Hamblett, Blackmore, Torgov, Handley, Ihle, Senter, Alley (bib17) 2005; 16
Xie, Audette, Hoffee, Lambert, Blattler (bib24) 2004; 308
Held-Feindt, Mentlein (bib14) 2002; 98
Diegmann, Junker, Gerstmayer, Bosio, Hindermann, Rosenhahn, von Eggeling (bib15) 2005
Jeffrey, Andreyka, Bernhardt, Kissler, Kline, Lenox, Moser, Nguyen, Okeley, Stone, Zhang, Senter (bib1) 2006; 17
Hishima, Fukayama, Hayashi, Fujii, Ooba, Funata, Koike (bib13) 2000; 24
Medarex, Inc: USA, 2005; pp 222.
Doronina, Mendelsohn, Bovee, Cerveny, Alley, Meyer, Oflazoglu, Toki, Sanderson, Zabinski, Wahl, Senter (bib18) 2006; 17
Doronina, Toki, Torgov, Mendelsohn, Cerveny, Chace, DeBlanc, Gearing, Bovee, Siegall, Francisco, Wahl, Meyer, Senter (bib19) 2003; 21
Saleh, Sugarman, Murray, Ostroff, Healey, Jones, Daniel, LeBherz, Brewer, Onetto, LoBuglio (bib23) 2000; 18
Desbene, Van, Michel, Koch, Tillequin, Fournier, Farjaudon, Monneret (bib2) 1998; 13
Nagamura, Saito (bib4) 1998; 387
Yasuzawa (10.1016/j.bmcl.2007.01.071_bib3) 1995; 43
Dubowchik (10.1016/j.bmcl.2007.01.071_bib21) 2002; 13
Hishima (10.1016/j.bmcl.2007.01.071_bib13) 2000; 24
Jeffrey (10.1016/j.bmcl.2007.01.071_bib1) 2006; 17
Yang (10.1016/j.bmcl.2007.01.071_bib10) 2002; 67
Sun (10.1016/j.bmcl.2007.01.071_bib17) 2005; 16
Wahl (10.1016/j.bmcl.2007.01.071_bib11) 2002; 62
Desbene (10.1016/j.bmcl.2007.01.071_bib2) 1998; 13
Atwell (10.1016/j.bmcl.2007.01.071_bib6) 1999; 42
Doronina (10.1016/j.bmcl.2007.01.071_bib19) 2003; 21
Nagamura (10.1016/j.bmcl.2007.01.071_bib4) 1998; 387
Junker (10.1016/j.bmcl.2007.01.071_bib12) 2005; 173
Boger (10.1016/j.bmcl.2007.01.071_bib5) 1994; 2
Suzawa (10.1016/j.bmcl.2007.01.071_bib9) 2000; 8
Held-Feindt (10.1016/j.bmcl.2007.01.071_bib14) 2002; 98
Tesselaar (10.1016/j.bmcl.2007.01.071_bib16) 1997; 159
Xie (10.1016/j.bmcl.2007.01.071_bib24) 2004; 308
Wu (10.1016/j.bmcl.2007.01.071_bib20) 2005; 23
Doronina (10.1016/j.bmcl.2007.01.071_bib18) 2006; 17
Jeffrey (10.1016/j.bmcl.2007.01.071_bib7) 2005; 48
Walker (10.1016/j.bmcl.2007.01.071_bib22) 2002; 12
10.1016/j.bmcl.2007.01.071_bib8
Diegmann (10.1016/j.bmcl.2007.01.071_bib15) 2005
Saleh (10.1016/j.bmcl.2007.01.071_bib23) 2000; 18
References_xml – volume: 173
  start-page: 2150
  year: 2005
  ident: bib12
  publication-title: J. Urol.
  contributor:
    fullname: Schubert
– volume: 159
  start-page: 4959
  year: 1997
  ident: bib16
  publication-title: J. Immunol.
  contributor:
    fullname: van Lier
– volume: 12
  start-page: 217
  year: 2002
  ident: bib22
  publication-title: Bioorg. Med. Chem. Lett.
  contributor:
    fullname: Firestone
– volume: 43
  start-page: 378
  year: 1995
  ident: bib3
  publication-title: Chem. Pharm. Bull. (Tokyo)
  contributor:
    fullname: Saitoh
– volume: 16
  start-page: 1282
  year: 2005
  ident: bib17
  publication-title: Bioconjug. Chem.
  contributor:
    fullname: Alley
– volume: 24
  start-page: 742
  year: 2000
  ident: bib13
  publication-title: Am. J. Surg. Pathol.
  contributor:
    fullname: Koike
– volume: 98
  start-page: 352
  year: 2002
  ident: bib14
  publication-title: Int. J. Cancer
  contributor:
    fullname: Mentlein
– volume: 67
  start-page: 8958
  year: 2002
  ident: bib10
  publication-title: J. Org. Chem.
  contributor:
    fullname: Denny
– volume: 23
  start-page: 1137
  year: 2005
  ident: bib20
  publication-title: Nat. Biotechnol.
  contributor:
    fullname: Senter
– volume: 62
  start-page: 3736
  year: 2002
  ident: bib11
  publication-title: Cancer Res.
  contributor:
    fullname: Francisco
– volume: 308
  start-page: 1073
  year: 2004
  ident: bib24
  publication-title: J. Pharmacol. Exp. Ther.
  contributor:
    fullname: Blattler
– year: 2005
  ident: bib15
  publication-title: Eur. J. Cancer
  contributor:
    fullname: von Eggeling
– volume: 13
  start-page: 955
  year: 1998
  ident: bib2
  publication-title: Anticancer Drug Des.
  contributor:
    fullname: Monneret
– volume: 387
  start-page: 1636
  year: 1998
  ident: bib4
  publication-title: Chem. Heterocycl. Comp.
  contributor:
    fullname: Saito
– volume: 48
  start-page: 1344
  year: 2005
  ident: bib7
  publication-title: J. Med. Chem.
  contributor:
    fullname: Senter
– volume: 18
  start-page: 2282
  year: 2000
  ident: bib23
  publication-title: J. Clin. Oncol.
  contributor:
    fullname: LoBuglio
– volume: 21
  start-page: 778
  year: 2003
  ident: bib19
  publication-title: Nat. Biotechnol.
  contributor:
    fullname: Senter
– volume: 2
  start-page: 115
  year: 1994
  ident: bib5
  publication-title: Bioorg. Med. Chem.
  contributor:
    fullname: Tarby
– volume: 42
  start-page: 3400
  year: 1999
  ident: bib6
  publication-title: J. Med. Chem.
  contributor:
    fullname: Denny
– volume: 17
  start-page: 831
  year: 2006
  ident: bib1
  publication-title: Bioconjug. Chem.
  contributor:
    fullname: Senter
– volume: 13
  start-page: 855
  year: 2002
  ident: bib21
  publication-title: Bioconjug. Chem.
  contributor:
    fullname: Trail
– volume: 17
  start-page: 114
  year: 2006
  ident: bib18
  publication-title: Bioconjug. Chem.
  contributor:
    fullname: Senter
– volume: 8
  start-page: 2175
  year: 2000
  ident: bib9
  publication-title: Bioorg. Med. Chem.
  contributor:
    fullname: Yamasaki
– volume: 98
  start-page: 352
  year: 2002
  ident: 10.1016/j.bmcl.2007.01.071_bib14
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.10207
  contributor:
    fullname: Held-Feindt
– volume: 42
  start-page: 3400
  year: 1999
  ident: 10.1016/j.bmcl.2007.01.071_bib6
  publication-title: J. Med. Chem.
  doi: 10.1021/jm990136b
  contributor:
    fullname: Atwell
– volume: 173
  start-page: 2150
  year: 2005
  ident: 10.1016/j.bmcl.2007.01.071_bib12
  publication-title: J. Urol.
  doi: 10.1097/01.ju.0000158121.49085.ba
  contributor:
    fullname: Junker
– ident: 10.1016/j.bmcl.2007.01.071_bib8
– volume: 21
  start-page: 778
  year: 2003
  ident: 10.1016/j.bmcl.2007.01.071_bib19
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt832
  contributor:
    fullname: Doronina
– volume: 13
  start-page: 955
  year: 1998
  ident: 10.1016/j.bmcl.2007.01.071_bib2
  publication-title: Anticancer Drug Des.
  contributor:
    fullname: Desbene
– volume: 2
  start-page: 115
  year: 1994
  ident: 10.1016/j.bmcl.2007.01.071_bib5
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/S0968-0896(00)82007-6
  contributor:
    fullname: Boger
– volume: 17
  start-page: 831
  year: 2006
  ident: 10.1016/j.bmcl.2007.01.071_bib1
  publication-title: Bioconjug. Chem.
  doi: 10.1021/bc0600214
  contributor:
    fullname: Jeffrey
– volume: 12
  start-page: 217
  year: 2002
  ident: 10.1016/j.bmcl.2007.01.071_bib22
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/S0960-894X(01)00707-7
  contributor:
    fullname: Walker
– volume: 67
  start-page: 8958
  year: 2002
  ident: 10.1016/j.bmcl.2007.01.071_bib10
  publication-title: J. Org. Chem.
  doi: 10.1021/jo0263115
  contributor:
    fullname: Yang
– volume: 387
  start-page: 1636
  year: 1998
  ident: 10.1016/j.bmcl.2007.01.071_bib4
  publication-title: Chem. Heterocycl. Comp.
  contributor:
    fullname: Nagamura
– volume: 8
  start-page: 2175
  year: 2000
  ident: 10.1016/j.bmcl.2007.01.071_bib9
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/S0968-0896(00)00157-7
  contributor:
    fullname: Suzawa
– year: 2005
  ident: 10.1016/j.bmcl.2007.01.071_bib15
  publication-title: Eur. J. Cancer
  contributor:
    fullname: Diegmann
– volume: 48
  start-page: 1344
  year: 2005
  ident: 10.1016/j.bmcl.2007.01.071_bib7
  publication-title: J. Med. Chem.
  doi: 10.1021/jm040137q
  contributor:
    fullname: Jeffrey
– volume: 18
  start-page: 2282
  year: 2000
  ident: 10.1016/j.bmcl.2007.01.071_bib23
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2000.18.11.2282
  contributor:
    fullname: Saleh
– volume: 24
  start-page: 742
  year: 2000
  ident: 10.1016/j.bmcl.2007.01.071_bib13
  publication-title: Am. J. Surg. Pathol.
  doi: 10.1097/00000478-200005000-00014
  contributor:
    fullname: Hishima
– volume: 43
  start-page: 378
  year: 1995
  ident: 10.1016/j.bmcl.2007.01.071_bib3
  publication-title: Chem. Pharm. Bull. (Tokyo)
  doi: 10.1248/cpb.43.378
  contributor:
    fullname: Yasuzawa
– volume: 13
  start-page: 855
  year: 2002
  ident: 10.1016/j.bmcl.2007.01.071_bib21
  publication-title: Bioconjug. Chem.
  doi: 10.1021/bc025536j
  contributor:
    fullname: Dubowchik
– volume: 17
  start-page: 114
  year: 2006
  ident: 10.1016/j.bmcl.2007.01.071_bib18
  publication-title: Bioconjug. Chem.
  doi: 10.1021/bc0502917
  contributor:
    fullname: Doronina
– volume: 23
  start-page: 1137
  year: 2005
  ident: 10.1016/j.bmcl.2007.01.071_bib20
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt1141
  contributor:
    fullname: Wu
– volume: 159
  start-page: 4959
  year: 1997
  ident: 10.1016/j.bmcl.2007.01.071_bib16
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.159.10.4959
  contributor:
    fullname: Tesselaar
– volume: 62
  start-page: 3736
  year: 2002
  ident: 10.1016/j.bmcl.2007.01.071_bib11
  publication-title: Cancer Res.
  contributor:
    fullname: Wahl
– volume: 16
  start-page: 1282
  year: 2005
  ident: 10.1016/j.bmcl.2007.01.071_bib17
  publication-title: Bioconjug. Chem.
  doi: 10.1021/bc050201y
  contributor:
    fullname: Sun
– volume: 308
  start-page: 1073
  year: 2004
  ident: 10.1016/j.bmcl.2007.01.071_bib24
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.103.060533
  contributor:
    fullname: Xie
SSID ssj0014044
Score 2.1040397
Snippet The minor groove binder β-glucuronide drug-linker 3 was constructed from amino CBI 1 and determined to be a substrate for Escherichia coli β-glucuronidase (EC...
The minor groove binder beta-glucuronide drug-linker 3 was constructed from amino CBI 1 and determined to be a substrate for Escherichia coli...
The minor groove binder beta -glucuronide drug-linker 3 was constructed from amino CBI 1 and determined to be a substrate for Escherichia coli beta...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 2278
SubjectTerms Aggregation
Anti-CD30
Anti-CD70
Antibodies, Monoclonal - therapeutic use
Antibody
Antigens, Neoplasm - immunology
Antineoplastic Agents, Alkylating - chemical synthesis
Antineoplastic Agents, Alkylating - pharmacokinetics
Biological and medical sciences
cAC10
Cancer
Cell Line, Tumor
Cell Survival - drug effects
Conjugate
Cross-Linking Reagents
Delivery
Drug
Drug Delivery Systems - methods
Drug-linker
Escherichia coli
Glucuronates - chemistry
Glucuronidase - metabolism
h1F6
Humans
Immunoconjugates - chemistry
Immunoconjugates - metabolism
Immunoconjugates - therapeutic use
Inhibitory Concentration 50
Linker
Medical sciences
Minor groove binder
Miscellaneous
Monoclonal
Pharmacology. Drug treatments
Prodrugs - chemical synthesis
Prodrugs - metabolism
Prodrugs - pharmacokinetics
Release
Solubility
Targeted
β-Glucuronidase
β-Glucuronide
Title Minor groove binder antibody conjugates employing a water soluble β-glucuronide linker
URI https://dx.doi.org/10.1016/j.bmcl.2007.01.071
https://www.ncbi.nlm.nih.gov/pubmed/17293111
https://search.proquest.com/docview/19797794
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6lrQRICEHKIzzKHigXy5EfG-_uMaSpCiJcGkRv1nq9aRO1dtXEQvlb_BB-E7MP2wmiCJC4ONFGjteezzuzM9_MIPRGUsHjPJiB5cYynyQgCyaZ8qMslESBwSsMGfPklH46Y0djMu506r6D7dh_lTSMgax15uxfSLv5UxiA7yBzOILU4fhHcp_Mi_LGOweDWNPSdTFEzZJczbMyX2uO-aLSjrOlp0yrX5Oi6H0VulSinpfOozocjQ_fRYbMXunKubnydJjX0XjrAPC8tA2hpAGPC9HrYiN1Bznv0mQKbVAUTc6YcbeaghCjfuOJPq_WyrH4iwtv2vwwKZeuN3O1uvCO23G1tuNHulmS97G_5bygOg5j0zetR63OqmkpTMY1mQQ-45a52Vd2YSYJ8WMSDLZWbrqBULa5DEe2L5BT6brkzy_VhfVcLPrZlbx05SxDXbKxVY4NZfFUz0pPKqCmDh7dQXsRLG6wtu4N34_PPjSxKxKYFsLNXbhULcsq_PlKt5lD96_FEl7Sme2ucvv2x5hB04fogdu_4KEF3iPUUUUX7Q8LsSqv1vgtNoxiE6rporujGgtddGfiSBz76IuBKLYQxRaiuIYobiGKG4higQ1EsYMo_v5tE57YwvMx-nw8no5OfNffw5dgNq583W52MMgp6ISEc6oEKA8SK0mIEgnJMyGlokmYc7DC2SxikYz5LFEZzwRTM07jJ2i3KAv1DOEwj2nGKVMRkyTKAxGImCf6kzCRcNlDXv2Y02tbxiWt-Y2LVAtF92OlaRCmIJQeGtSSSJ0hag3MFIDz2_MOtsTWXgruFFQn7aHXtRxTeP46NicKVVbLNOQUdmKc9NBTK972XNj-xmCRPP_HSb1A99o37yXaXd1U6hXaWebVgUPuD-NIyfY
link.rule.ids 315,782,786,27933,27934
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Minor+groove+binder+antibody+conjugates+employing+a+water+soluble+%CE%B2-glucuronide+linker&rft.jtitle=Bioorganic+%26+medicinal+chemistry+letters&rft.au=Jeffrey%2C+Scott+C.&rft.au=Nguyen%2C+Minh+T.&rft.au=Moser%2C+Ruth+F.&rft.au=Meyer%2C+Damon+L.&rft.date=2007-04-15&rft.pub=Elsevier+Ltd&rft.issn=0960-894X&rft.eissn=1464-3405&rft.volume=17&rft.issue=8&rft.spage=2278&rft.epage=2280&rft_id=info:doi/10.1016%2Fj.bmcl.2007.01.071&rft.externalDocID=S0960894X07001217
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-894X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-894X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-894X&client=summon